Matrix Partners China joins $100m Series C round in Peijia Medical

Matrix Partners China joins $100m Series C round in Peijia Medical

Dmitry Stolyarov, a heart surgeon, holds a stent, which is inserted into constricted coronary arteries to help keep them open and normalise blood flow, as he performs a surgery on a patient with a blood clot in the carotid artery at the Federal Center of Cardiovascular Surgery in the Siberian city of Krasnoyarsk, Russia, September 28, 2016. REUTERS/Ilya Naymushin

Chinese medical instrument provider Peijia Medical has raised 700 million yuan ($100 million) in its  Series C round from Matrix Partners China, Lilly Asia Ventures, Grand Flight, China SDIC Gaoxin Industrial Investment Corp and China Chengtong Holdings Group, per a company filing. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter